Vaccination News Home Page            Scandals            subscribe Vaccination NewsLetter

 

http://www.sciencedirect.com/science?_ob=IssueURL&_tockey=%23TOC%235188%232003%23999789980%23427515%23FLA%23Volume_21,_Issues_19-20,_Pages_2223-2690_(2_June_2003)%2BMHepatitis_A_Vaccines%2BMEdited_by_A._Mele_and_T.O._Jefferson&_auth=y&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=e2b9b817b4892da89ec07e6b2a672a00

 

 

Vaccine
Copyright © 2003 Elsevier Science Ltd. All rights reserved

Volume 21, Issues 19-20, Pages 2223-2690 (2 June 2003)
Hepatitis A Vaccines
Edited by A. Mele and T.O. Jefferson
   
           Selected Display Checked Docs  | E-mail Articles View:
1.
The use of hepatitis A vaccine in Italy––evidence-based recommendations from an expert panel, Page 2223
Alfonso Mele and Tom Jefferson
Abstract | Full Text + Links | PDF (25 K)
 
2.
Risk groups for hepatitis A virus infection, Pages 2224-2233
Elisabetta Franco, Cristina Giambi, Rita Ialacci, Rosa C. Coppola and Alessandro R. Zanetti
Abstract | Full Text + Links | PDF (114 K)
 
3.
Hepatitis A: post-exposure prophylaxis, Pages 2234-2237
Gloria Taliani and Giovanni Battista Gaeta
Abstract | Full Text + Links | PDF (60 K)
 
4.
HAV infection in chronic liver disease: a rationale for vaccination, Pages 2238-2241
Piero L. Almasio and Pietro Amoroso
Abstract | Full Text + Links | PDF (50 K)
 
5.
The effectiveness and safety of hepatitis A vaccine: a systematic review, Pages 2242-2245
Vittorio Demicheli and Donatella Tiberti
Abstract | Full Text + Links | PDF (46 K)
 
6.
The role of vaccine in controlling hepatitis A epidemics, Pages 2246-2249
P. D'Argenio, B. Adamo, R. Cirrincione and G. Gallo
Abstract | Full Text + Links | PDF (60 K)
 
7.
The use of hepatitis a vaccination in Italy: an economic evaluation, Pages 2250-2257
Vittorio Demicheli, Emanuela Carniglia and Stefania Fucci
Abstract | Full Text + Links | PDF (409 K)
 
8.
Simian immunodeficiency virus: possible effects of deworming and tuberculin extrapolated to HIV/AIDS, Pages 2258-2259
John E. Fincham, Miles B. Markus and Vera J. Adams
Abstract | Full Text + Links | PDF (35 K)
 
9.
Comments on the paper "The effectiveness of serogroup C meningococcal vaccine estimated from routine surveillance data" [P. Rivest, R. Allard, Vaccine 20 (2002) 2533–2536], Pages 2260-2261
Philippe De Wals and Gaston De Serres
Abstract | Full Text + Links | PDF (35 K)
 
10.
Reply to the letter of Drs De Wals and De Serres, Page 2262
Robert Allard and Paul Rivest
Abstract | Full Text + Links | PDF (28 K)
 
11.
Genetic immunization is augmented by murine polyomavirus VP1 pseudocapsids, Pages 2263-2267
E. Rollman, T. Ramqvist, B. Zuber, K. Tegerstedt, A. Kjerrström Zuber, J. Klingström, L. Eriksson, K. Ljungberg, J. Hinkula, B. Wahren and T. Dalianis
Abstract | Full Text + Links | PDF (80 K)
 
12.
CD40-targeted adenoviral gene transfer to dendritic cells through the use of a novel bispecific single-chain Fv antibody enhances cytotoxic T cell activation, Pages 2268-2272
Joana G. Brandão, Rik J. Scheper, Sinéad M. Lougheed, David T. Curiel, Bryan W. Tillman, Winald R. Gerritsen, Alfons J. M. van den Eertwegh, Herbert M. Pinedo, Hidde J. Haisma and Tanja D. de Gruijl
Abstract | Full Text + Links | PDF (158 K)
 
13.
Development and clinical testing of multivalent vaccines based on a diphtheria–tetanus–acellular pertussis vaccine: difficulties encountered and lessons learned, Pages 2273-2287
Carine Capiau, Jan Poolman, Bernard Hoet, Hugues Bogaerts and Francis Andre
Abstract | Full Text + Links | PDF (303 K)
 
14.
Cellular immune responses to helper-free HSV-1 amplicon particles encoding HIV-1 gp120 are enhanced by DNA priming, Pages 2288-2297
Xiuqing Wang, Rebecca D. Wiley, Thomas G. Evans, William J. Bowers, Howard J. Federoff and Stephen Dewhurst
Abstract | Full Text + Links | PDF (413 K)
 
15.
Nature, evolution, and appraisal of adverse events and antibody response associated with the fifth consecutive dose of a five-component acellular pertussis-based combination vaccine, Pages 2298-2306
Scott A. Halperin, David Scheifele, Elaine Mills, Roland Guasparini, Garry Humphreys, Luis Barreto and Bruce Smith
Abstract | Full Text + Links | PDF (111 K)
 
16.
Gene expression after vaccination of mice with formulations of diphtheria toxoid or tetanus toxoid and different adjuvants: identification of shared and vaccine-specific genes in spleen lymphocytes, Pages 2307-2317
Karin Regnström, Eva Ragnarsson and Per Artursson
Abstract | Full Text + Links | PDF (408 K)
 
17.
Mechanisms of enhanced antigen-specific T cell response following vaccination with a novel peptide-based cancer vaccine and systemic interleukin-2 (IL-2), Pages 2318-2328
Christophe L. Nguyen, Mohamed L. Salem, Mark P. Rubinstein, Marina Demcheva, John N. Vournakis, David J. Cole and William E. Gillanders
Abstract | Full Text + Links | PDF (325 K)
 
18.
Modifications of the catalytic and binding subunits of pertussis toxin by formaldehyde: effects on toxicity and immunogenicity, Pages 2329-2337
Sarah Fowler, Dorothy K. -L. Xing, Barbara Bolgiano, Chun-Ting Yuen and Michael J. Corbel
Abstract | Full Text + Links | PDF (233 K)
 
19.
Immunogenicity of a Japanese encephalitis DNA vaccine candidate in cynomolgus monkeys, Pages 2338-2345
Kiyoshi Tanabayashi, Ryozaburo Mukai, Akio Yamada, Tomohiko Takasaki, Ichiro Kurane, Masaoki Yamaoka, Aya Terazawa and Eiji Konishi
Abstract | Full Text + Links | PDF (126 K)
 
20.
Oculo-respiratory syndrome following influenza vaccination: evidence for occurrence with more than one influenza vaccine, Pages 2346-2353
Gaston De Serres, Nicole Boulianne, Bernard Duval, Louis Rochette, Jean Luc Grenier, Renée Roussel, Danièle Donaldson, Michèle Tremblay, Eveline Toth, Suzanne Ménard et al.
Abstract | Full Text + Links | PDF (82 K)
 
21.
The clinical spectrum of the oculo-respiratory syndrome after influenza vaccination, Pages 2354-2361
Gaston De Serres, Jean Luc Grenier, Eveline Toth, Suzanne Ménard, Renée Roussel, Michèle Tremblay, Monique Douville Fradet, Monique Landry, Yves Robert and Danuta M. Skowronski
Abstract | Full Text + Links | PDF (225 K)
 
22.
Roles of anti-hemagglutinin IgA and IgG antibodies in different sites of the respiratory tract of vaccinated mice in preventing lethal influenza pneumonia, Pages 2362-2371
Reiko Ito, Yasuko Asahi Ozaki, Tomoki Yoshikawa, Hideki Hasegawa, Yuko Sato, Yujiro Suzuki, Ryosuke Inoue, Tsuneo Morishima, Naomi Kondo, Tetsutaro Sata et al.
Abstract | Full Text + Links | PDF (300 K)
 
23.
Optimization of DNA vaccination immune responses in dairy cows: effect of injection site and the targeting efficacy of antigen-bCTLA-4 complex, Pages 2372-2382
Lulzim Shkreta, Brian G. Talbot and Pierre Lacasse
Abstract | Full Text + Links | PDF (341 K)
 
24.
Antigen entrapped in the escheriosomes leads to the generation of CD4+ helper and CD8+ cytotoxic T cell response, Pages 2383-2393
Faisal M. Syed, Masood A. Khan, Tahseen H. Nasti, Nadeem Ahmad and Owais Mohammad
Abstract | Full Text + Links | PDF (223 K)
 
25.
Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi children 18–36 months of age, Pages 2394-2403
Firdausi Qadri, Tanvir Ahmed, Firoz Ahmed, R. Bradley Sack, David A. Sack, Ann-Mari Svennerholm and the PTE study group
Abstract | Full Text + Links | PDF (164 K)
 
26.
Identification of specific Hep G2 cell binding regions in Plasmodium falciparum sporozoite–threonine–asparagine-rich protein (STARP), Pages 2404-2411
Ramsés López, Javier Garcia, Alvaro Puentes, Hernando Curtidor, Marisol Ocampo, Ricardo Vera, Luis Eduardo Rodriguez, Jorge Suarez, Mauricio Urquiza, Ana Liliana Rodríguez et al.
Abstract | Full Text + Links | PDF (365 K)
 
27.
Seroprevalence of Bordetella pertussis antibodies in Flanders (Belgium), Pages 2412-2417
Marie Van der Wielen, Pierre Van Damme, Koen Van Herck, Susanna Schlegel-Haueter and Claire-Anne Siegrist
Abstract | Full Text + Links | PDF (191 K)
 
28.
Effect of Vitamin A supplementation on the immune response to measles vaccination, Pages 2418-2420
Thomas Cherian, Sneha Varkki, P. Raghupathy, Sam Ratnam and Ranjit K. Chandra
Abstract | Full Text + Links | PDF (47 K)
 
29.
Why do older people not get immunised against influenza?: A community survey, Pages 2421-2427
Meirion R. Evans and Phil A. Watson
Abstract | Full Text + Links | PDF (73 K)
 
30.
The association between psychosocial factors and vaccine-induced cytokine production, Pages 2428-2432
Mary S. Hayney, Gayle Dienberg Love, Jessica M. Buck, Carol D. Ryff, Burton Singer and Daniel Muller
Abstract | Full Text + Links | PDF (136 K)
 
31.
Immunogenicity and efficacy of recombinant subunit vaccines against phocid herpesvirus type 1, Pages 2433-2440
Byron E. E. Martina, Marco W. G. van de Bildt, Thijs Kuiken, Geert van Amerongen and Albert D. M. E. Osterhaus
Abstract | Full Text + Links | PDF (154 K)
 
32.
Effect of priming/booster immunisation protocols on immune response to canine parvovirus peptide induced by vaccination with a chimaeric plant virus construct, Pages 2441-2447
B. L. Nicholas, F. R. Brennan, W. D. O. Hamilton and D. Wakelin
Abstract | Full Text + Links | PDF (151 K)
 
33.
Immunogenicity of a new purified fusion protein vaccine to respiratory syncytial virus: a multi-center trial in children with cystic fibrosis, Pages 2448-2460
Pedro A. Piedra, Stanley G. Cron, Alan Jewell, Nicole Hamblett, Ruth McBride, Melisa A. Palacio, Richard Ginsberg, Christopher M. Oermann, Peter W. Hiatt and Purified Fusion Protein Vaccine Study Group
Abstract | Full Text + Links | PDF (266 K)
 
34.
A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant, Pages 2461-2467
Scott A. Halperin, Gary Van Nest, Bruce Smith, Simin Abtahi, Heather Whiley and Joseph J. Eiden
Abstract | Full Text + Links | PDF (117 K)
 
35.
Analysis of PorA variable region 3 in meningococci: implications for vaccine policy?, Pages 2468-2473
S. C. Clarke, M. A. Diggle, P. Mölling, M. Unemo and P. Olcén
Abstract | Full Text + Links | PDF (78 K)
 
36.
Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA and vaccinia recombinant vectors expressing LACK., Pages 2474-2484
Maria J. Ramiro, Juan J. Zárate, Tobias Hanke, Dolores Rodriguez, Juan R. Rodriguez, Mariano Esteban, Javier Lucientes, Juan A. Castillo and Vicente Larraga
Abstract | Full Text + Links | PDF (300 K)
 
37.
OM-174, a new adjuvant with a potential for human use, induces a protective response when administered with the synthetic C-terminal fragment 242–310 from the circumsporozoite protein of Plasmodium berghei, Pages 2485-2491
Valentin Meraldi, Régine Audran, Jackeline F. Romero, Vincent Brossard, Jacques Bauer, José Alejandro López and Giampietro Corradin
Abstract | Full Text + Links | PDF (158 K)
 
38.
CpG-motifs enhance initial and sustained primary tetanus-specific antibody secreting cell responses in spleen and bone marrow, but are more effective in adult than in neonatal mice, Pages 2492-2499
Maria Pihlgren, Chantal Tougne, Nadine Schallert, Paola Bozzotti, Paul-Henri Lambert and Claire-Anne Siegrist
Abstract | Full Text + Links | PDF (174 K)
 
39.
A single amino acid substitution in a recombinant G protein vaccine drastically curtails protective immunity against respiratory syncytial virus (RSV), Pages 2500-2505
Yan Huang and Robert Anderson
Abstract | Full Text + Links | PDF (164 K)
 
40.
Enhanced tumour growth after DNA vaccination against human papilloma virus E7 oncoprotein: evidence for tumour-induced immune deviation, Pages 2506-2515
Minal T. Kotecha, Razi K. Afghan, Eleni Vasilikopoulou, Erica Wilson, Philip Marsh, W. Martin Kast, D. Huw Davies and Wilson Caparros-Wanderley
Abstract | Full Text + Links | PDF (196 K)
 
41.
The domain III fragment of Japanese encephalitis virus envelope protein: mouse immunogenicity and liposome adjuvanticity, Pages 2516-2522
Suh-Chin Wu, Ching-Hung Yu, Cheng-Wen Lin and I-Min Chu
Abstract | Full Text + Links | PDF (229 K)
 
42.
Antibody response to vaccination and psychosocial stress in humans: relationships and mechanisms, Pages 2523-2534
Victoria E. Burns, Douglas Carroll, Christopher Ring and Mark Drayson
Abstract | Full Text + Links | PDF (121 K)
 
43.
Three types of immunotherapics against pythiosis insidiosi developed and evaluated, Pages 2535-2540
J. M. Santurio, A. T. Leal, A. B. M. Leal, R. Festugatto, I. Lubeck, E. S. V. Sallis, M. V. Copetti, S. H. Alves and L. Ferreiro
Abstract | Full Text + Links | PDF (683 K)
 
44.
The incidence of shingles and its implications for vaccination policy, Pages 2541-2547
Rachel S. Chapman, Kenneth W. Cross and Douglas M. Fleming
Abstract | Full Text + Links | PDF (129 K)
 
45.
Murine antibody response to intranasally administered enterotoxigenic Escherichia coli colonization factor CS6, Pages 2548-2555
Arthur J. de Lorimier, Wyatt Byrd, Eric R. Hall, William M. Vaughan, Douglas Tang, Zachary J. Roberts, Charles E. McQueen and Frederick J. Cassels
Abstract | Full Text + Links | PDF (176 K)
 
46.
Safety and protective efficacy of porcine reproductive and respiratory syndrome recombinant virus vaccines in young pigs, Pages 2556-2563
M. H. Verheije, M. V. Kroese, I. F. A. van der Linden, E. A. de Boer-Luijtze, P. A. van Rijn, J. M. A. Pol, J. J. M. Meulenberg and P. J. G. M. Steverink
Abstract | Full Text + Links | PDF (131 K)
 
47.
The cost-burden of paediatric pneumococcal disease in the UK and the potential cost-effectiveness of prevention using 7-valent pneumococcal conjugate vaccine, Pages 2564-2572
E. David G. McIntosh, Peter Conway, Julie Willingham and Adam Lloyd
Abstract | Full Text + Links | PDF (222 K)
 
48.
Effect of infant immunisation with meningococcus serogroup C–CRM197 conjugate vaccine on diphtheria immunity and reactogenicity in pre-school aged children, Pages 2573-2579
Jodie McVernon, Jenny MacLennan, Elizabeth Clutterbuck, Jim Buttery and E. Richard Moxon
Abstract | Full Text + Links | PDF (88 K)
 
49.
The effect of measles–mumps–rubella (MMR) immunization on the immune responses of previously immunized primary school children, Pages 2580-2588
Bracha Rager-Zisman, Elina Bazarsky, Agneta Skibin, Shlomo Chamney, Ilana Belmaker, Iris Shai, Ella Kordysh and Diane E. Griffin
Abstract | Full Text + Links | PDF (234 K)
 
50.
IgG1/IgG2 antibody dichotomy in sera of vaccinated or naturally infected dogs with visceral leishmaniosis, Pages 2589-2597
Carolina de Oliveira Mendes, Edilma Paraguai de Souza, Gulnara Patrícia Borja-Cabrera, Leopoldina Maria Melo Batista, Miriam Aparecida dos Santos, Luciana Ellner Parra, Ingrid Menz, Marcos Palatnik and Clarisa Beatriz Palatnik de Sousa
Abstract | Full Text + Links | PDF (414 K)
 
51.
A comparison of DNA vaccines for the rabies-related virus, Mokola, Pages 2598-2606
L. H. Nel, M. Niezgoda, C. A. Hanlon, P. A. Morril, P. A. Yager and C. E. Rupprecht
Abstract | Full Text + Links | PDF (118 K)
 
52.
Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine, Pages 2607-2615
Robert H. Purcell, Hanh Nguyen, Max Shapiro, Ronald E. Engle, Sugantha Govindarajan, William C. Blackwelder, Doris C. Wong, Jean-Paul Prieels and Suzanne U. Emerson
Abstract | Full Text + Links | PDF (146 K)
 
53.
Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2, Pages 2616-2626
Krystyna Mozdzanowska, JinQi Feng, Mark Eid, Goran Kragol, Mare Cudic, Laszlo Otvos, Jr. and Walter Gerhard
Abstract | Full Text + Links | PDF (252 K)
 
54.